Zura Bio Ltd Sustainability Reports
Zura Bio Limited is a clinical-stage biotechnology company focused on developing dual-pathway antibodies for autoimmune and inflammatory diseases. The company's pipeline includes therapeutic candidates targeting mechanisms such as IL-17A, BAFF, and IL-7R alpha.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300LQXD6M2MIQFN24
FIGI: BBG011FJXVZ5
2 reports from 2023 to 2024